Cargando…

Drug Resistance Mechanisms in Mycobacterium tuberculosis

Tuberculosis (TB) is a serious public health problem worldwide. Its situation is worsened by the presence of multidrug resistant (MDR) strains of Mycobacterium tuberculosis, the causative agent of the disease. In recent years, even more serious forms of drug resistance have been reported. A better k...

Descripción completa

Detalles Bibliográficos
Autores principales: Palomino, Juan Carlos, Martin, Anandi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790366/
https://www.ncbi.nlm.nih.gov/pubmed/27025748
http://dx.doi.org/10.3390/antibiotics3030317
_version_ 1782420980804616192
author Palomino, Juan Carlos
Martin, Anandi
author_facet Palomino, Juan Carlos
Martin, Anandi
author_sort Palomino, Juan Carlos
collection PubMed
description Tuberculosis (TB) is a serious public health problem worldwide. Its situation is worsened by the presence of multidrug resistant (MDR) strains of Mycobacterium tuberculosis, the causative agent of the disease. In recent years, even more serious forms of drug resistance have been reported. A better knowledge of the mechanisms of drug resistance of M. tuberculosis and the relevant molecular mechanisms involved will improve the available techniques for rapid drug resistance detection and will help to explore new targets for drug activity and development. This review article discusses the mechanisms of action of anti-tuberculosis drugs and the molecular basis of drug resistance in M. tuberculosis.
format Online
Article
Text
id pubmed-4790366
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-47903662016-03-24 Drug Resistance Mechanisms in Mycobacterium tuberculosis Palomino, Juan Carlos Martin, Anandi Antibiotics (Basel) Review Tuberculosis (TB) is a serious public health problem worldwide. Its situation is worsened by the presence of multidrug resistant (MDR) strains of Mycobacterium tuberculosis, the causative agent of the disease. In recent years, even more serious forms of drug resistance have been reported. A better knowledge of the mechanisms of drug resistance of M. tuberculosis and the relevant molecular mechanisms involved will improve the available techniques for rapid drug resistance detection and will help to explore new targets for drug activity and development. This review article discusses the mechanisms of action of anti-tuberculosis drugs and the molecular basis of drug resistance in M. tuberculosis. MDPI 2014-07-02 /pmc/articles/PMC4790366/ /pubmed/27025748 http://dx.doi.org/10.3390/antibiotics3030317 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Palomino, Juan Carlos
Martin, Anandi
Drug Resistance Mechanisms in Mycobacterium tuberculosis
title Drug Resistance Mechanisms in Mycobacterium tuberculosis
title_full Drug Resistance Mechanisms in Mycobacterium tuberculosis
title_fullStr Drug Resistance Mechanisms in Mycobacterium tuberculosis
title_full_unstemmed Drug Resistance Mechanisms in Mycobacterium tuberculosis
title_short Drug Resistance Mechanisms in Mycobacterium tuberculosis
title_sort drug resistance mechanisms in mycobacterium tuberculosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790366/
https://www.ncbi.nlm.nih.gov/pubmed/27025748
http://dx.doi.org/10.3390/antibiotics3030317
work_keys_str_mv AT palominojuancarlos drugresistancemechanismsinmycobacteriumtuberculosis
AT martinanandi drugresistancemechanismsinmycobacteriumtuberculosis